(Q43165989)

15 November 2017

Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach (English)

1 reference

15 November 2017

0 references

Katsunori Iijima

1

1 reference

15 November 2017

Yasuhiko Abe

2

1 reference

15 November 2017

Ryosuke Kikuchi

3

1 reference

15 November 2017

Tomoyuki Koike

4

1 reference

15 November 2017

Shuichi Ohara

5

1 reference

15 November 2017

Pentti Sipponen

6

1 reference

15 November 2017

Tooru Shimosegawa

7

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

World Journal of Gastroenterology

15 November 2017

1 reference

15 November 2017

15

1 reference

15 November 2017

7

1 reference

15 November 2017

853-859

1 reference

Gastric cancer screening using the serum pepsinogen test method

15 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Low circulating levels of gastrin-17 in patients with Barrett's esophagus

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Possibility of non-invasive diagnosis of gastric mucosal precancerous changes

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Helicobacter pylori infection and the development of gastric cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Rapid quantitative assessment of gastric corpus atrophy in tissue sections

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Accuracy of screening for gastric cancer using serum pepsinogen concentrations

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Histological diagnosis of precancerous lesions of the stomach: a reliability study.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Helicobacter pylori, pepsinogens and gastrin: relationship with age and development of atrophic gastritis

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Gastric precancerous process in a high risk population: cohort follow-up

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Fasting levels of serum gastrin in different functional and morphologic states of the antrofundal mucosa. An analysis of 860 subjects.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Histologic and serum risk markers for noncardia early gastric cancer

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Usefulness of gastric cancer screening using the serum pepsinogen test method

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer?

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653386

Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer

15 August 2018

1 reference

12 December 2020

Apparent reversal of early gastric mucosal atrophy after triple therapy for Helicobacter pylori

1 reference

12 December 2020

Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia

1 reference

12 December 2020

Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study

1 reference

12 December 2020

An 18-year follow-up study of chronic gastritis and Helicobacter pylori association of CagA positivity with development of atrophy and activity of gastritis

1 reference

12 December 2020

Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels

1 reference

12 December 2020

Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer

1 reference

12 December 2020

The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.15.853

1 reference

15 November 2017

1 reference

15 November 2017

1 reference